| Followers | 842 |
| Posts | 122793 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Saturday, December 25, 2010 11:53:04 AM
[Updated for SEC filings through 12/17/10.]
The table entries below include both ordinary and restricted
shares and both vested and non-vested options.
*10b5-1 selling plan in effect.
Shares Options
Officers
*Craig Wheeler (CEO) 338,281 675,000
*G Venkataraman (SVP/R&D) 358,421 157,325
*John Bishop (SVP/Pharma) 46,657 116,864
*Richard Shea (CFO) 39,085 249,200
*Bruce Leicher (Gen Cnsl) 38,144 137,050
*James Roach (CMO) 17,648 205,250
Directors
John Clarke 77,123 126,000
Bruce Downey 0 45,000
Marsha Fanucci 0 126,000
Peter Hutt 67,863 131,000
*Bennett Shapiro 7,000 140,450
Elizabeth Stoner 0 79,200
James Sulat 0 60,000
======================== ========= =========
All thirteen insiders 990,507 2,247,339
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
